Unknown

Dataset Information

0

Nonhomologous end joining and V(D)J recombination require an additional factor.

ABSTRACT: DNA nonhomologous end-joining (NHEJ) is the major pathway for repairing DNA double-strand breaks in mammalian cells. It also functions to carry out rearrangements at the specialized breaks introduced during V(D)J recombination. Here, we describe a patient with T(-)B(-) severe combined immunodeficiency, whose cells have defects closely resembling those of NHEJ-defective rodent cells. Cells derived from this patient show dramatic radiosensitivity, decreased double-strand break rejoining, and reduced fidelity in signal and coding joint formation during V(D)J recombination. Detailed examination indicates that the patient is defective neither in the known factors involved in NHEJ in mammals (Ku70, Ku80, DNA-dependent protein kinase catalytic subunit, Xrcc4, DNA ligase IV, or Artemis) nor in the Mre11/Rad50/Nbs1 complex, whose homologue in Saccharomyces cerevisiae functions in NHEJ. These results provide strong evidence that additional activities are crucial for NHEJ and V(D)J recombination in mammals.

SUBMITTER: Dai Y 

PROVIDER: S-EPMC151363 | biostudies-literature | 2003 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Nonhomologous end joining and V(D)J recombination require an additional factor.

Dai Y Y   Kysela B B   Hanakahi L A LA   Manolis K K   Riballo E E   Stumm M M   Harville T O TO   West S C SC   Oettinger M A MA   Jeggo P A PA  

Proceedings of the National Academy of Sciences of the United States of America 20030225 5

DNA nonhomologous end-joining (NHEJ) is the major pathway for repairing DNA double-strand breaks in mammalian cells. It also functions to carry out rearrangements at the specialized breaks introduced during V(D)J recombination. Here, we describe a patient with T(-)B(-) severe combined immunodeficiency, whose cells have defects closely resembling those of NHEJ-defective rodent cells. Cells derived from this patient show dramatic radiosensitivity, decreased double-strand break rejoining, and reduc  ...[more]

Similar Datasets

Unknown Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination.
| S-EPMC2605234 | biostudies-literature
Unknown Measuring nonhomologous end-joining, homologous recombination and alternative end-joining simultaneously at an endogenous locus in any transfectable human cell.
| S-EPMC8287935 | biostudies-literature
Unknown PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways.
| S-EPMC4027158 | biostudies-literature
Unknown LINC complexes promote homologous recombination in part through inhibition of nonhomologous end joining.
| S-EPMC5166498 | biostudies-literature
Unknown The deSUMOylase SENP2 coordinates homologous recombination and nonhomologous end joining by independent mechanisms.
| S-EPMC6411010 | biostudies-literature
Unknown Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates.
| S-EPMC2704125 | biostudies-literature
Unknown Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells.
| S-EPMC3044391 | biostudies-literature
Unknown Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development.
| S-EPMC1502498 | biostudies-literature
Unknown Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome.
| S-EPMC7526497 | biostudies-literature
Unknown Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV-deficient B cells.
| S-EPMC2585838 | biostudies-literature